Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1313, 2001-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Capecitabine is well tolerated and has clinically significant beneficial effects
Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. :
Rosuvastatin well tolerated by a broad range of patients
Reactions Weekly, Vol. 1, Iss. 1029, 2004-01 ,pp. :
The anticonvulsant levetiracetam `appears to be promising' in the treatment of action myoclonus
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
Natalizumab in MS well tolerated
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :